ORGANON

📅 Upcoming

🕒 Recent(90d)

News

• Beyond China: Five other overseas destinations for biopharma dollars
  As geopolitical tensions between the U.S. and China grow increasingly complicated, here are five alternative territories for biotech investments.
  biospace · 22d ago
• Will a ‘reset’ reignite investment in women’s health startups?
  After peaking in 2024, venture investments in startups involved in the space declined last year. But a broader adoption of AI and a widening definition of what constitutes women’s health could spur…
  biopharma_dive · 1mo ago
• India’s pharma industry is going global. But can it catch up to China?
  A record Sun Pharma acquisition signals global ambitions. But infrastructure, capital and policy gaps could stand in the way of India becoming an R&D powerhouse.
  biopharma_dive · 4mo ago
• Lilly, Gilead lead pharma’s M&A boom
  Deal volume in 2026 is substantially outpacing last year, and activity is being driven by interest in cancer and autoimmune disease drugs.
  biopharma_dive · 4mo ago
• Lilly to buy startup Ajax in bid for a better JAK drug
  Worth up to $2.3 billion overall, the deal hands Lilly a drug designed to address the weaknesses of a class of medicines used to treat myelofibrosis and other diseases.
  biopharma_dive · 5mo ago
• STAT+: Pharmalittle: We’re reading about a Lilly deal, an Intellia CRISPR rare-disease treatment, and more
  Intellia disclosed that a single dose of its gene editing treatment dramatically reduced swelling attacks in patients with hereditary angioedema
  stat · 5mo ago
• Sun Pharma to buy Organon for $11.75B in major portfolio expansion
  Indian drug giant Sun Pharma has lined up an $11.75 billion acquisition of Organon, a women’s health and biosimilar maker spun out of Merck in 2021. The all-cash deal came in at $14 per share ...
  endpoints · 5mo ago